XB-404

N/A

Report date: 2026/02/10 20:00:22

Base Information

Drug NameXB-404

Drug Alias NameXB-404XB404

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 modulatorsTyrosine-protein kinase transmembrane receptor ROR2 modulatorsDNA topoisomerase I modulators

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Tyrosine-protein kinase transmembrane receptor ROR2DNA topoisomerase I

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesExelixis Inc

China Registration ClassN/A

Develop Information

Active CompaniesExelixis Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A